Analysts Expect Boston Scientific Co. (NYSE:BSX) Will Announce Quarterly Sales of $3.22 Billion

Analysts expect Boston Scientific Co. (NYSE:BSX – Get Rating) to post sales of $3.22 billion for the current fiscal quarter, according to Zacks Investment Research. Nine analysts have provided estimates for Boston Scientific’s earnings, with the lowest sales estimate coming in at $3.20 billion and the highest estimate coming in at $3.24 billion. Boston Scientific […]

Related Keywords

Boston ,Massachusetts ,United States ,Canada ,Kentucky ,America ,Danielj Brennan ,Raymond James ,Morgan Stanley ,Boston Scientific Corporation ,National Bank ,Securities Exchange Commission ,Amplius Wealth Advisors ,Kentucky Retirement Systems Insurance Trust Fund ,Zacks Investment Research ,Parnassus Investments ,Boston Scientific Company Profile Get Rating ,Sectoral Asset Management Inc ,Boston Scientific ,Boston Scientific Co ,Get Rating ,Zacks Investment ,Exchange Commission ,Wealth Advisors ,Retirement Systems Insurance Trust Fund ,Asset Management Inc ,Scientific Company Profile ,Scientific Corporation ,Nyse Bsx ,Bsx ,Medical ,10113710 ,Ratings ,Consensus ,